Article Details

FDA grants new heart failure implant its breakthrough device designation

Retrieved on: 2024-07-22 19:17:03

Tags for this article:

Click the tags to see associated articles and topics

FDA grants new heart failure implant its breakthrough device designation. View article details on hiswai:

Summary

The article explains how Restore Medical's ContraBand device, designed to treat heart failure with reduced ejection fraction, relates to advancements in healthcare technology, specifically in managing heart diseases like heart failure, while excluding patients with significant pulmonary hypertension or right heart failure.

Article found on: cardiovascularbusiness.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up